ELEVA Capital
Romain Zana is a Senior Buyside Analyst at ELEVA Capital since November 2019, focusing on Healthcare, Household, and Personal Care sectors with expertise in Long Only and Long/Short strategies. Previously, Romain served as an Equity Sell Side Analyst at Exane for twelve years, covering MedTech and Services, including major companies such as Siemens Healthineers and Philips. Prior experience includes roles at Bryan, Garnier & Co, as a Healthcare Sell Side Equity Analyst, and GlaxoSmithKline in the Economic & Strategy department, where Romain analyzed drug pricing and market impacts of healthcare reforms. Romain's early career included a pharmacist position in a retail pharmacy and a project assistant role at HAPTO Biotech, working on a stem cell project. Romain holds a Master's degree in Finance from Paris-Pantheon-Assas University and a Doctor of Pharmacy from Université Paris Cité.
This person is not in the org chart
This person is not in any teams
ELEVA Capital
Founded in 2014 by Eric Bendahan, ELEVA Capital is an independent investment manager. Building on its long-standing expertise in European equities, ELEVA Capital has gradually developed other areas of expertise in small & mid caps, impact investing, fixed income, multi-asset and structured products through its subsidiary ELEVA Solutions. The firm is proud of its independence and looks to differentiate through its performance, client proximity and integrity. In addition, ELEVA Capital has a long-term, innovative and industry-leading partnership with UNICEF, allocating c.10% of the firms profits via the ELEVA Foundation. ELEVA Capital is authorized and regulated by the Autorité des Marchés Financiers (the “AMF”) in France under number GP-17000015; ELEVA Solutions is registered with ORIAS as a tied agent and insurance broker (registration number 23001946).